Conditions

Search for a condition by name and view related trials.

Atrial Fibrillation

Related Clinical Trials

Title	Acronym	Phase
"Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"	CRYPTONITE	N/A
Detection of Occult Paroxysmal Atrial Fibrillation After Stroke Using Prolonged Ambulatory Cardiac Monitoring		N/A
Screening for Atrial Fibrillation, After Ischemic Stroke		N/A
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial	EAST	4
BIOTRONIK IMPACT Study	IMPACT	4
Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism		N/A
Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence		N/A
Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation	BOREALIS-AF	3
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event	EMBRACE	N/A
Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial		4
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation		3
Left Atrial Appendage Occlusion Study II	LAAOSII	3
Anticoagulation in Stent Intervention	MUSICA-2	4
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation		2
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048		2
Left Atrial Distensibility to Predict Prognosis in Consecutive Patients		N/A
TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics		N/A
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial	CABANA	3
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke		2
Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial	CABANA	N/A
Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy	PREVAIL	3
Safety of Cardioversion of Acute Atrial Fibrillation		N/A
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation		2
Evaluating the Relationship Between Fatty Acids and Heart Disease		N/A
Pharmacogenetics and Cardiovascular Events		N/A
Atrial Fibrillation Incidence, Risk Factors and Genetics		N/A
Atrial Fibrillation and the Risk for Neurological Complications		4
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm		3
PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin		2
Drug Interaction Between Paracetamol and Warfarin	INPAWA2	4
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients	FORESPEAK-0	2
Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)	EVOLVE	N/A
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation	OPAL-2	2
After Discharge Management of Low Income Frail Elderly		N/A
Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor	TRIPPS	N/A
Effect of Balloon Cryoablation on Left Atrial Function	CRYO-LA	3
Atrial Fibrillation (AF) Clinic to Improve the Treatment of Patients With Atrial Fibrillation.	AFClinic	N/A
AMPLATZER Cardiac Plug Clinical Trial		1
Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making	AFIB	1
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)		3
Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)		3
Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study	TIARA	N/A
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)		3
WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation		2/ 3
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients		2
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate		3
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information		N/A
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation	ATHENA	3
Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin	EXPLORE-Xa	2
The Genetic Basis of Atrial Fibrillation (AF)		N/A
The Home INR Study	THINRS	4
Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation	EngageAFTIMI48	3
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring		N/A
Clarification of Optimal Anticoagulation Through Genetics	COAG	3
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation		3
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation	ARISTOTLE	3
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)	ACTIVE I	3
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)		3
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)		3
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation	ACT I	3
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation	DIONYSOS	3
A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045)	ACT V	3
Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers		2
Omega 3 Fatty Acids and Atrial Fibrillation		N/A
The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation		N/A
Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation		N/A
A Phase III Study of Apixaban in Patients With Atrial Fibrillation	AVERROES	3
Graz Study on the Risk of Atrial Fibrillation	GRAF	4
GLORIA-AF Registry Program - Second and Third Phases		N/A
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation		4
Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage		N/A
Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients	SCARF	N/A
Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation		N/A
Left Atrial Appendage Occlusion Study III	LAAOS III	N/A
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)	SAMURAI-NVAF	N/A
Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden		N/A